# MMTV-like Viruses and Human Breast Cancer: Evidence for Causality

**Authors:** Mónica L. Acevedo, Francisco Aguayo, Julio C. Osorio, Luis N. Ardiles, Gloria M. Calaf

PMC · DOI: 10.3390/cimb48020157 · Current Issues in Molecular Biology · 2026-01-30

## TL;DR

This paper reviews evidence linking MMTV-like viruses to human breast cancer, suggesting a possible causal relationship for some cases.

## Contribution

The paper proposes a causality framework integrating detection methods, epidemiology, and human-relevant mechanisms to assess MMTV-like viruses in breast cancer.

## Key findings

- MMTV-like DNA and viral proteins are detected in some human breast tumors.
- Causal plausibility is 'possible' overall but 'probable' only for a subset of sporadic tumors.
- Standardized assays and mechanistic evidence are needed to confirm causality.

## Abstract

Mouse Mammary Tumor Virus (MMTV) is an established mammary carcinogen in mice, yet the relevance of MMTV-like agents to human breast cancer remains debated. Across cohorts worldwide, PCR-based detection of MMTV-like DNA, in situ RNA localization, and immunohistochemical detection of viral proteins have been reported in a subset of tumors and, in some studies, in pre-invasive lesions; however, results are heterogeneous and vulnerable to methodological confounding, including murine DNA contamination and variable assay design. Here, we synthesize the evidence through a causality-oriented framework that integrates (i) standardized multi-target detection with mandatory contamination controls, (ii) epidemiologic designs that explicitly stratify sporadic versus hereditary/BRCA-driven disease, and (iii) mechanistic endpoints that are demonstrably human-relevant (e.g., in situ viral RNA/protein in tumor cells, integration-site mapping, and functional consequences of viral gene products in human models). Given current evidence, the overall causal plausibility is best considered “possible,” rising to “probable” only for a restricted subset of sporadic tumors, provided that future studies verify bona fide infection in situ using standardized multi-target assays, rigorous murine exclusion controls, and mechanistic evidence linking viral expression and/or integration to tumor cell biology. Without these endpoints, association studies alone are unlikely to resolve causality or enable meaningful clinical translation.

## Linked entities

- **Genes:** Brca2 (BRCA2, DNA repair associated) [NCBI Gene 37916]
- **Diseases:** breast cancer (MONDO:0004989)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** SOCS2 (suppressor of cytokine signaling 2) [NCBI Gene 8835] {aka CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, RPP14 (ribonuclease P/MRP subunit p14) [NCBI Gene 11102] {aka P14}, CISH (cytokine inducible SH2 containing protein) [NCBI Gene 1154] {aka BACTS2, CIS, CIS-1, G18, SOCS}, NOTCH4 (notch receptor 4) [NCBI Gene 4855] {aka INT3}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, SYK (spleen associated tyrosine kinase) [NCBI Gene 6850] {aka IMD82, p72-Syk}, ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, APOBEC3A_B (APOBEC3A and APOBEC3B deletion hybrid) [NCBI Gene 100913187] {aka A3A, APOBEC3A}, PDPN (podoplanin) [NCBI Gene 10630] {aka AGGRUS, D2-40, GP36, GP40, Gp38, HT1A-1}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}, CNTN2 (contactin 2) [NCBI Gene 6900] {aka AXT, EPEO5, FAME5, TAG-1, TAX, TAX1}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, IAPP (islet amyloid polypeptide) [NCBI Gene 3375] {aka DAP, IAP}, SAG (S-antigen visual arrestin) [NCBI Gene 6295] {aka RP47, RP96, S-AG}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}
- **Diseases:** viral infections (MESH:D014777), tumorigenic (MESH:D002471), benign breast lesions (MESH:D061325), deaths (MESH:D003643), infection (MESH:D007239), BC (MESH:D001943), Ductal Carcinoma (MESH:D044584), lymphoma (MESH:D008223), BRCA (MESH:D001941), mammary (MESH:D005348), injury to (MESH:D014947), microsatellite (MESH:D053842), ADH (MESH:D002285), cancer (MESH:D009369), Carcinogenesis (MESH:D063646), mammary tumors (MESH:D015674), hereditary disease (MESH:D030342)
- **Chemicals:** BioRender (-), sugar (MESH:D000073893)
- **Species:** Mus musculus domesticus (western European house mouse, subspecies) [taxon 10092], Bovine leukemia virus (no rank) [taxon 11901], Homo sapiens (human, species) [taxon 9606], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Human betaherpesvirus 5 (no rank) [taxon 10359], hepatitis C virus [taxon 11103], Betaretrovirus (genus) [taxon 140052], Xenotropic MuLV-related virus (no rank) [taxon 438045], Human mammary tumor virus (species) [taxon 341730], Mus musculus (house mouse, species) [taxon 10090], Hepatitis B virus (no rank) [taxon 10407], Mouse mammary tumor virus (no rank) [taxon 11757], Human betaretrovirus (no rank) [taxon 189458]
- **Mutations:** serine 18, G-to-A, serine 65, Ser18Ala, Y > F

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939075/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939075/full.md

## References

101 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939075/full.md

---
Source: https://tomesphere.com/paper/PMC12939075